Literature DB >> 14665855

Renal tumors in young adults.

S E Eggener1, J N Rubenstein, N D Smith, R B Nadler, J Kontak, R C Flanigan, W B Waters, M Picken, S C Campbell, J R Rubenstein.   

Abstract

PURPOSE: The clinical and pathological features of solid or complex cystic renal masses in young adults have not been defined. We present our experience with patients 17 to 45 years old with such renal masses to define the incidence of malignant vs benign lesions, familial tendencies and clinical outcomes.
MATERIALS AND METHODS: The medical records of all patients 17 to 45 years old who presented with a solid or suspicious complex cystic renal mass at 2 tertiary care hospitals between 1988 and 2002 were retrospectively reviewed. Pertinent clinical information was compiled, including age, gender, mode of presentation, renal function, year and type of surgery, pathological analysis and survival data.
RESULTS: There were 114 evaluable patients who underwent a total of 119 nephrectomies. Mean patient age was 37.1 years and males comprised 56.1% of the population. Twelve patients had familial renal cell carcinoma (RCC), the von Hippel-Lindau syndrome. Mode of presentation for patients with sporadic disease was symptomatic (55.9%), incidental (35.3%) or unknown (8.8%). Radical nephrectomy, partial nephrectomy and nephroureterectomy were performed in 80 kidneys (67.2%), 37 (31.1%) and 2 (1.7%), respectively. Malignant lesions comprised 79.8% of all masses and 95.8% of these were renal cell carcinoma. Of the RCCs 75.8% were grade 1 or 2 and 89% were organ confined. Young women were much more likely than men to have a benign lesion (36.0% vs 9.5%, p <0.01) and the diversity of histologies was impressive (of the 24 total benign masses 9 were different tumor types). With an average followup of 38.3 months overall survival is 90.2%. Among patients with RCC 84.9% are alive and cancer-free, 11.6% are dead from disease and 3.5% are alive with recurrent disease.
CONCLUSIONS: We report the largest known series of solid or suspicious complex renal masses in young adults. As expected, familial tumors are more common in this population. While RCC is the most common tumor, a wide variety of potential pathological outcomes are possible, particularly in women, who were much more likely to have a benign lesion. RCC in this patient population appears to have a favorable prognosis, despite symptomatic presentation in the majority of cases.

Entities:  

Mesh:

Year:  2004        PMID: 14665855     DOI: 10.1097/01.ju.0000099028.95679.52

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size.

Authors:  Brian R Winters; John L Gore; Sarah K Holt; Jonathan D Harper; Daniel W Lin; Jonathan L Wright
Journal:  Urol Oncol       Date:  2015-08-28       Impact factor: 3.498

Review 2.  Should Small Renal Masses Be Biopsied?

Authors:  Ricardo R N Leão; Ardalan E Ahmad; Patrick O Richard
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

3.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

4.  Histopathology of surgically treated renal tumours in young adults: a developing country perspective.

Authors:  Muhammed Mubarak; Javed I Kazi; Rehan Mohsin; Altaf Hashmi; Syed Ali Anwer Naqvi; Syed Adeeb Ul Hassan Rizvi
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-16       Impact factor: 4.553

5.  Clinicopathologic features of renal cell carcinoma in young adults: a comparison study with renal cell carcinoma in older patients.

Authors:  Jae Hee Suh; Tina Oak; Jae Y Ro; Luan D Truong; Alberto G Ayala; Steven S Shen
Journal:  Int J Clin Exp Pathol       Date:  2009-01-30

6.  An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.

Authors:  Mark P Purdue; Lee E Moore; Maria J Merino; Paolo Boffetta; Joanne S Colt; Kendra L Schwartz; Vladimir Bencko; Faith G Davis; Barry I Graubard; Vladimir Janout; Julie J Ruterbusch; Jennifer Beebe-Dimmer; Michele L Cote; Brian Shuch; Dana Mates; Jonathan N Hofmann; Lenka Foretova; Nathaniel Rothman; Neonilia Szeszenia-Dabrowska; Vsevolod Matveev; Sholom Wacholder; David Zaridze; W Marston Linehan; Paul Brennan; Wong-Ho Chow
Journal:  Int J Cancer       Date:  2013-01-15       Impact factor: 7.396

7.  The relationship between histopathology and age factor in patients who were operated for renal masses.

Authors:  Taha Numan Yıkılmaz; Okan Baş; Ali İhsan Arık; Fatih Hızlı; Halil Başar
Journal:  Turk J Urol       Date:  2015-06

8.  Renal cell carcinoma under 35 years of age: comparison of survival rates for symptomatic and asymptomatic patients.

Authors:  Vahudin Zugor; Swetlana Fridel; Berthold Lausen; Günter E Schott; Reinhard Kühn; Apostolos P Labanaris
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

9.  Renal cell carcinoma in young and old patients--is there a difference?

Authors:  R Houston Thompson; Maria A Ordonez; Alexia Iasonos; Fernando P Secin; Bertrand Guillonneau; Paul Russo; Karim Touijer
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

10.  Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis.

Authors:  Benjamin J Scoll; Yu-Ning Wong; Brian L Egleston; David A Kunkle; Ismail R Saad; Robert G Uzzo
Journal:  J Urol       Date:  2008-12-13       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.